Lethal acute lung injury and hypoglycemia after subcutaneous administration of monochloroacetic acid

Junko Kato1, Tomotaro Dote, Hiroyasu Shimizu

  • 1Department of Hygiene and Public Health, Osaka Medical College, 2-7 Daigakumachi, Takatsuki City, Osaka 569-8686, Japan. in1073@poh.osaka-med.ac.jp

Insights

Monochloroacetic acid (MCA) exposure causes lethal toxicity, leading to severe hypoglycemia and lung injury in rats. These effects, particularly hypoglycemia and impaired gas exchange, appear to be the primary causes of death.

Area of Science:

  • Toxicology
  • Environmental Health
  • Pulmonary Medicine

Background:

  • Cutaneous exposure to monochloroacetic acid (MCA) can induce acute lethal toxicity.
  • While hepato-renal dysfunction is implicated, the precise mechanisms and primary organs responsible for MCA-induced mortality remain unclear.
  • Respiratory failure is suspected as a potential cause of death in some reported MCA exposure cases.

Purpose of the Study:

  • To investigate the dose-response relationship between MCA exposure and its toxic effects in rats.
  • To determine the roles of hypoglycemia and lung injury in MCA-induced acute lethal toxicity.
  • To identify the primary target organs contributing to mortality following MCA exposure.

Main Methods:

  • Rats were subcutaneously administered varying doses of MCA (108, 135, or 163 mg/kg).
  • Serum glucose levels, blood gases, and bronchoalveolar lavage fluid (BALF) parameters were analyzed at 2 and 4 hours post-exposure.
  • Parameters assessed included lactate dehydrogenase (LDH) and total cell counts in BALF to evaluate lung injury.

Main Results:

  • At 2 hours post-MCA administration, no significant pulmonary injury or hypoglycemia was observed.
  • However, dose-dependent increases in BALF LDH and total cells were noted, indicating early lung damage.
  • By 4 hours, severe hypoglycemia was evident, and significant alveolar gas exchange dysfunction was observed in the highest dose group (163 mg/kg).

Conclusions:

  • MCA exposure induces significant lung injury and severe hypoglycemia in a dose- and time-dependent manner.
  • The observed hypoglycemia and lung injury, particularly impaired alveolar gas exchange, are strongly associated with mortality.
  • These findings suggest that hypoglycemia and pulmonary damage are critical factors in the acute lethal toxicity of monochloroacetic acid.

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: